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Introduction
　Elevated insulin concentrations are reportedly inversely 
associated with serum high-density lipoprotein (HDL) cho-
lesterol concentrations1 and positively associated with serum 
triglyceride (TG) concentrations.2 Furthermore, a higher 
TG-HDL cholesterol ratio (TG-HDL) was found to indicate 
insulin resistance in general populations,3 overweight indi-
viduals,4 and patients with type 2 diabetes.5 The classifica-
tion of patients with diabetes according to TG-HDL levels 
tertiles (Shimizuʼs diabetes classification) in our studies6-9 
was based on the assumption that diabetes in patients with 
high a TG-HDL ratio is mainly caused by insulin resistance 
with few compensatory changes in β-cell function, while 
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that of patients with a low TG-HDL ratio is mainly caused 
by β-cell dysfunction. Our previous studies found that cat-
egorizing patients with type 2 diabetes by TG-HDL ratio 
may be an effective tool for risk estimation of atherosclero-
sis6 and chronic kidney disease (CKD),8 as the presence of 
type 2 diabetes with a high TG-HDL ratio constitutes a risk 
for atherosclerosis6 and CKD,8 but the presence of type 2 
diabetes with an intermediate and low TG-HDL ratio does 
not.
　One study reported that a high white blood cell (WBC) 
count was associated with the presence of coronary heart 
disease, peripheral arterial disease, and stroke,10 and another 
study reported that WBC count was related to early and ad-
vanced atherosclerosis independent of other risk factors.11 
Another study reported sex differences in the association be-
tween WBC count and risk for CKD;12 no significant asso-
ciation was observed for men while a significant positive 
association was observed for women. 
　However, no study has been published on the associations 
between WBC count and type 2 diabetes categorized by TG-
HDL ratios.
　To investigate these associations, we conducted a cross-
sectional study of 3,998 subjects (1,430 men and 2,568 
women) aged 30-89 who participated in a survey on cardio-




　Consent forms were available in Japanese to ensure com-
prehensive understanding of the study objectives, and writ-
ten informed consent was provided by all participants. This 
study was approved by the Ethics Committee for Use of Hu-
mans of Nagasaki University (project registration number 
0501120073).
　The survey population included 4,269 participants (1,538 
men and 2,731 women) aged 30 to 89 years, all residents of 
the western rural community of the Goto Islands. A total of 
271 individuals (108 men and 163 women) with missing 
data were excluded, leaving 3,998 participants (1,430 men 
and 2,568 women) for enrolment in this study.
　The mean age of the study population was 65.5 years 
(±10.6 SD; range 30-89) for men and 63.8 years (±11.4 
SD; range 30-89) for women.
Data collection and laboratory measurements
　Trained interviewers obtained information on smoking 
status, drinking status, medical history, use of antihyperten-
sive agents, and use of medication for diabetes mellitus. 
Body weight and height were measured with an automatic 
body composition analyzer (BF-220; Tanita, Tokyo, Japan) 
at the time of drawing blood. Systolic and diastolic blood 
pressures were recorded at rest.
　Fasting blood samples were collected in an EDTA-2K tube 
and a siliconized tube. Samples from the siliconized tube were 
used to separate the serum by centrifugation after blood co-
agulation. Samples from the EDTA-2K tube were used for 
measuring WBC count using the flow cytometry method. Se-
rum triglycerides, serum HDL cholesterol, serum aspartate 
aminotransferase (AST), serum γ-glutamyltranspeptidase 
(γ-GTP), serum creatinine, and HbA1C were measured with 
standard laboratory procedures.
　The glomerular filtration rate (GFR) was estimated with an 
established method with three variations recently proposed by 
the working group of the Japanese Chronic Kidney Disease 
Initiative.13 According to this adaptation, GFR (mL/min/1.73m2) 
= 194×(serum creatinine [enzyme method])-1.094×(age)-0.287
×(0.739 for women). 
　HbA1c, as defined by the National Glycohemoglobin Stan-
dardization Program (NGSP), was calculated with the fol-
lowing equation, which was recently proposed by the work-
ing group of the Japanese Diabetes Society (JDS): HbA1c 
(NGSP) = HbA1c (JDS) + 0.4%. Presence of diabetes was 
defined as HbA1c (NGSP) ≥ 6.5%, and/or initiation of glu-
cose-lowering medication or insulin therapy.14 We further 
defined subtypes of diabetes by calculating tertiles of TG-
HDL ratios for all the participants: low TG-HDL diabetes 
(median TG-HDL ratio: 1.00 for men, 0.90 for women), in-
termediate TG-HDL diabetes (2.08 for men, 1.77 for wom-
en), and high TG-HDL diabetes (4.37 for men, 3.59 for 
women) as in our previous study.6,7
Statistical analysis
　Age-adjusted clinical characteristics were determined by 
least square method. TG-HDL categories for all subjects 
were established according to the sex-specific tertiles of TG-
HDL ratios. Logistic regression models were used for calcu-
lating odds ratios (ORs) and 95% confidence intervals 
(95%CIs) of diabetes with TG-HDL ratios and a 1 SD (stan-
dard deviation) increment (1,538/μL for men, 1,382/μL for 
women) for associations with WBC count. Two different ap-
proaches were used to adjust for confounding factors. First, 
the data were adjusted only for age. Second, we included 
other possible confounding factors, namely smoking status 
(never smoker, former smoker, current smoker), alcohol 
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consumption (non-drinker, current light to moderate drinker 
[1-6 times/week], current heavy drinker [every day]), sys-
tolic blood pressure (mmHg), antihypertensive medication 
use (no, yes), history of cardiovascular disease (no, yes), 
body mass index (BMI [kg/m2]), AST (IU/L), γ-GTP 
(IU/L), and estimated GFR (mL/min/1.73m2).
　All statistical analyses were performed with the SAS sys-
tem for Windows (version 9.3; SAS Inc., Cary, NC, USA). 
All p-values for statistical tests were two-tailed, and values 
of <0.05 were regarded as statistically significant.
Results
　Of the 3,998 subjects entered in this study, 302 (147 men 
and 155 women) were identified as having type 2 diabetes: 
127 (57 men and 70 women) had high TG-HDL diabetes and 
84 (48 men and 36 women) had low TG-HDL diabetes.
　The age-adjusted clinical characteristics of the study pop-
ulation are shown in Table 1. Compared with women, men 
showed a significantly higher prevalence of current drinker 
and current smoker, significantly higher levels of γ-GTP 
and serum creatinine, and significantly lower levels of HDL 
for total subjects, participants with diabetes, and participants 
without diabetes. Men also showed a significantly higher 
prevalence of history of cardiovascular disease and higher 
levels of GFR for total subjects and non-diabetes partici-
pants; no such significant associations were observed for 
men with diabetes.
　Table 2 shows the sex-specific, age-adjusted characteris-
tics of the study populations by tertile of WBC count for all 
subjects. For both men and women, systolic blood pressure, 
diastolic blood pressure, antihypertensive medication use, 
BMI, current smoker, TG, and TG-HDL ratio were positive-
ly associated with WBC count, and HDL was inversely as-
sociated with WBC count. Moreover, γ-GTP was positively 
associated with WBC count for men, whereas serum creati-
nine was positively associated and GFR was inversely asso-
ciated with WBC count for women.
　Table 3 shows ORs and 95%CIs of diabetes and its TG-
HDL subtypes in relation to WBC count. No significant as-
sociation between WBC count and diabetes was observed 
for men, but a significant positive association was seen for 
women. Analysis of the association between WBC and dia-
betes categorized by TG-HDL level showed a significant 
positive association for high TG-HDL diabetes but no sig-
nificant association for low TG-HDL diabetes. For interme-
diate TG-HDL diabetes, even multivariable OR showed no 
significant associations for either men or women, but women 
tended to show a positive association.
　To exclude the influence of menopausal status, we further 
investigated the associations between 1 SD increments in 
WBC count and the risk of high, intermediate, and low-TG-
HDL diabetes for elderly women (≥60 years) only and found 
essentially the same associations: the multivariable ORs and 
95%CIs of high, intermediate, and low TG-HDL ratio diabe-
tes were 1.82 (95%CI: 1.39-2.37), 1.30 (95%CI: 0.94-1.80), 
and 0.95 (95%CI: 0.64-1.42), respectively.
Table 1. Age-adjusted characteristics for study populations 
Total subjects Diabetes Non-diabetes 
Total Men Women p Total Men Women p Total Men Women p
No. at risk 3,998 1,430 2,568 302 147 155 3,696 1,283 2,413
Age, years 64.4 ± 11.1 65.5 ± 10.6 63.8 ± 11.4 68.6 ± 8.7 68.5 ± 8.2 68.6 ± 9.3 64.1 ± 11.2 65.2 ± 10.8 63.5 ± 11.4
Systolic blood pressure, mmHg 141 141 141 0.716 146 145 146 0.732 141 141 141 0.765 
Diastolic blood pressure, mmHg 83 85 82 <0.001 83 83 83 0.628 83 85 82 <0.001
Antihypertensive medication use, % 30.0 27.9 31.1 0.024 40.1 33.4 46.4 0.020 29.2 27.5 30.1 0.078 
Body mass index, kg/m2 23.3 23.7 23.1 <0.001 24.3 23.9 24.6 0.108 23.2 23.7 23.0 <0.001
Current drinker, % 25.0 50.8 10.6 <0.001 25.2 43.5 7.8 <0.001 24.9 51.5 10.8 <0.001
Current smoker, % 11.2 24.6 3.6 <0.001 12.3 21.1 3.9 <0.001 11.1 25.0 3.7 <0.001
History of cardiovascular disease, % 7.5 9.4 6.4 <0.001 11.9 13.6 10.3 0.367 7.1 9.1 6.1 <0.001
Serum triglycerides (TG), mg/dL 121 126 118 0.001 137 139 136 0.742 120 125 117 0.002 
Serum HDL-cholesterol (HDL), mg/dL 59 55 61 <0.001 55 52 58 0.002 59 55 62 <0.001
TG-to-HDL ratio 2.35 2.66 2.18 <0.001 2.87 3.12 2.62 0.121 2.31 2.61 2.15 <0.001
Serum aspartate aminotransferase, IU/L 23 25 22 <0.001 26 27 26 0.667 23 25 22 <0.001
Serum γ -glutamyltranspeptidase, IU/L 32 44 24 <0.001 38 46 30 <0.001 31 44 24 <0.001
Serum creatinine, mg/dL 0.77 0.90 0.70 <0.001 0.78 0.87 0.69 <0.001 0.77 0.90 0.70 <0.001
Glomerular filtration rate, mL/min/1.73m2 69.1 70.7 68.3 <0.001 70.5 71.3 69.7 0.444 69.0 70.5 68.2 <0.001
Age: mean  ± standard deviation. p: age-adjsuted p values for sex differences. 
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　In part of our study 1,407 men and 2,541 women had data 
on carotid intima-media thickness (CIMT). We found that 
WBC count was significantly associated with risk of carotid 
atherosclerosis (CIMT ≥1.1 mm) for men but not for women. 
The age-adjusted ORs of 1 SD increments of WBC count for 
carotid atherosclerosis were 1.20 (95%CI: 1.05-1.38) for 
men and 1.04 (95%CI: 0.93-1.17) for women.
　Furthermore, we evaluated the risk of CKD. No signifi-
cant association was observed for men, but a significant 
positive association was observed for women. The age-ad-
justed OR for 1 SD increments of WBC count for CKD were 
1.05 (95%CI: 0.93-1.19) for men and 1.25 (95%CI: 1.14-
1.36) for women.
Table 2. Sex-specific relationships between age-adjusted mean values and  tertiles of white blood cell (WBC) count
WBC count tertiles
T1 (low) T2 T3 (high) p for trend
Men
　No. at risk 476 477 477
　Age, years 66.8 ± 10.6 65.5 ± 10.4 64.3 ± 10.6
　Systolic blood pressure, mmHg 140 143 143 0.009 
　Diastolic blood pressure, mmHg 83 85 85 0.007 
　Antihypertensive medication use, % 25.2 28.9 34.6 0.003 
　Body mass index, kg/m2 23.1 23.8 24.2 <0.001
　Current drinker, % 47.8 50.7 52.3 0.363 
　Current smoker, % 14.9 20.8 36.9 <0.001
　History of cardiovascular disease, % 8.6 12.2 9.3 0.138 
　Serum triglycerides (TG), mg/dL 110 120 149 <0.001
　Serum HDL-cholesterol (HDL), mg/dL 57 55 51 <0.001
　TG-to-HDL ratio 2.22 2.48 3.29 <0.001
　Serum aspartate aminotransferase, IU/L 25 25 25 0.394 
　Serum γ -glutamyltranspeptidase, IU/L 41 41 49 0.027 
　Serum creatinine, mg/dL 0.88 0.91 0.92 0.070 
　Glomerular filtration rate, mL/min/1.73m2 71.4 69.6 69.2 0.086 
Women
　No. at risk 876 836 856
　Age, years 64.0 ± 11.2 64.1 ± 11.2 63.2 ± 11.7
　Systolic blood pressure, mmHg 139 140 143 <0.001
　Diastolic blood pressure, mmHg 82 82 84 <0.001
　Antihypertensive medication use, % 26.0 28.0 36.7 <0.001
　Body mass index, kg/m2 22.7 23.0 23.6 <0.001
　Current drinker, % 10.5 11.3 10.8 0.875 
　Current smoker, % 1.9 3.4 6.4 <0.001
　History of cardiovascular disease, % 6.7 6.0 5.6 0.597 
　Serum triglycerides (TG), mg/dL 103 117 135 <0.001
　Serum HDL-cholesterol (HDL), mg/dL 64 61 59 <0.001
　TG-to-HDL ratio 1.84 2.15 2.57 <0.001
　Serum aspartate aminotransferase, IU/L 23 22 22 0.108 
　Serum γ -glutamyltranspeptidase, IU/L 25 23 26 0.105 
　Serum creatinine, mg/dL 0.68 0.70 0.72 <0.001
　Glomerular filtration rate, mL/min/1.73m2 70.9 68.3 66.5 <0.001
 Age: mean values. WBC tertiles: < 5,120 /μL, 5,120-6,300 /μL, and > 6,300 /μL for men and < 4,930 /μL, 4,930-6,010 /μL, and > 6,010/μL for women. 
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Table 3. Odds ratio (OR) and 95% confidence intervals (CI) for diabetes stratified by white blood cell (WBC) count
WBC count tertiles 1 SD increment in 
T1 (low) T2 T3 (high) P for trend WBC
Men
　　No. at risk 476 477 477
　Diabetes
　　No. of cases (%) 45 (9.5) 45 (9.4) 57 (11.9)
　　Age-adjusted OR 1.00 1.04 (0.67-1.61) 1.42 (0.93-2.16) 0.097 1.07 (0.89-1.27)
　　Multivariable OR 1.00 1.04 (0.67-1.62) 1.45 (0.94-2.25) 0.093 1.07 (0.90-1.29)
　High TG-HDL diabetes
　　No. of cases (%) 12 (2.5) 14 (2.9) 31 (6.5)
　　Age-adjusted OR 1.00 1.19 (0.54-2.60) 2.78 (1.40-5.49) 0.002 1.43 (1.09-1.89)
　　Multivariable OR 1.00 1.06 (0.48-2.36) 2.58 (1.27-5.28) 0.005 1.39 (1.04-1.85)
　Intermediate TG-HDL diabetes
　　No. of cases (%) 15 (3.2) 15 (3.1) 12 (2.5)
　　Age-adjusted OR 1.00 1.06 (0.51-2.20) 0.89 (0.41-1.94) 0.784 0.93 (0.68-1.28)
　　Multivariable OR 1.00 1.04 (0.49-2.19) 0.90 (0.40-2.02) 0.802 0.93 (0.67-1.30)
　Low TG-HDL diabetes
　　No. of cases (%) 18 (3.8) 16 (3.4) 14 (2.9)
　　Age-adjusted OR 1.00 0.93 (0.47-1.86) 0.85 (0.42-1.75) 0.664 0.84 (0.63-1.11)
　　Multivariable OR 1.00 1.09 (0.54-2.22) 0.97 (0.46-2.05) 0.953 0.88 (0.66-1.19)
Women
　　No. at risk 876 836 856
　Diabetes
　　No. of cases (%) 35 (4.0) 52 (6.2) 68 (7.9)
　　Age-adjusted OR 1.00 1.60 (1.03-2.49) 2.15 (1.41-3.29) <0.001 1.43 (1.22-1.68)
　　Multivariable OR 1.00 1.66 (1.06-2.61) 2.12 (1.37-3.28) <0.001 1.41 (1.19-1.66)
　High TG-HDL diabetes
　　No. of cases (%) 9 (1.0) 21 (2.5) 40 (4.7)
　　Age-adjusted OR 1.00 2.49 (1.13-5.47) 4.87 (2.34-10.10) <0.001 1.90 (1.51-2.38)
　　Multivariable OR 1.00 2.54 (1.13-5.69) 4.61 (2.16-9.82) <0.001 1.83 (1.45-2.33)
　Intermediate TG-HDL diabetes
　　No. of cases (%) 10 (1.1) 18 (2.2) 21 (2.5)
　　Age-adjusted OR 1.00 1.91 (0.88-4.17) 2.26 (1.05-4.83) 0.038 1.34 (1.01-1.77)
　　Multivariable OR 1.00 1.95 (0.89-4.31) 2.16 (0.99-4.70) 0.059 1.30 (0.98-1.73)
　Low TG-HDL diabetes
　　No. of cases (%) 16 (1.8) 13 (1.6) 7 (0.8)
　　Age-adjusted OR 1.00 0.85 (0.40-1.78) 0.46 (0.19-1.11) 0.089 0.80 (0.57-1.12)
　　Multivariable OR 1.00 1.06 (0.50-2.28) 0.60 (0.24-1.50) 0.320 0.91 (0.64-1.29)
Multivariable OR: adjusted further for age, systolic blood pressure, antihypertensive medication use, history of cardiovascular disease, body mass index, 
smoking, alcohol intake, serum aspartate aminotransferase, serum γ -glutamyltranspeptidase, and glomerular filtration rate.  WBC count tertiles:  <5,120/
μL, 5,120-6,300/μL, and >6300/μL for men and <4,930/μL, 4,930-6,010/μL, and >6,010/μL for women.
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　The major findings of this study were that significant pos-
itive associations independent from cardiovascular risk were 
observed for high TG-HDL diabetes but not for low TG-
HDL diabetes in both men and women.
　A previous study of ours that included 1,344 Japanese 
men found that diabetes combined with a high TG-HDL ra-
tio was a risk factor for atherosclerosis (diagnosed as CIMT 
≥1.1 mm) and increased arterial stiffness (diagnosed as car-
dio-ankle vascular index (CAVI) ≥8.0) but that intermediate 
and low TG-HDL diabetes were not. In that study, the multi-
variable-adjusted ORs and 95%CIs of atherosclerosis and 
increased arterial stiffness for diabetes were, respectively, 
2.57 (95%CI: 1.32-5.02) and 3.56 (95%CI: 1.50-8.46) for 
high TG-HDL diabetes, 0.76 (95%CI: 0.29-2.00) and 0.68 
(95%CI: 0.26-1.78) for intermediate TG-HDL diabetes, and 
1.17 (95%CI: 0.52-2.63) and 0.80 (95%CI: 0.33-1.90) for 
low TG-HDL diabetes.6 Another study with 554 subjects 
with primary dyslipidemia and 246 normolipidemic subjects 
reported that WBC count was related to early and advanced 
measures of atherosclerosis independent of other risk fac-
tors. The sex- and age-adjusted probability of carotid athero-
sclerosis and femoral plaque increased by 20% (OR, 1.20; 
95%CI: 1.10-1.31) and 25% (OR, 1.25; 95%CI: 1.13-1.38), 
respectively, for each 1000/mm3 WBC increment.11 Another 
previous sex-specific study with 1,165 men and 2,573 wom-
en reported that WBC count was correlated with CAVI in 
men (β=0.61, p=0.043), but not in women (β=0.35, 
p=0.17).15 This study is compatible with our present addi-
tional analysis that shows WBC count was significantly as-
sociated with carotid atherosclerosis (CIMT ≥1.1 mm) in 
men but not in women.
　We also reported a sex-combined study (1,153 men and 
1,916 women aged 60-89 years) that showed that high but 
not low TG-HDL diabetes constituted a significant risk for 
CKD (GFR <60 mL/min/1.73m2). The adjusted ORs of clas-
sical cardiovascular risk factors for CKD were 1.52 (95%CI: 
1.01-2.29) for high TG-HDL diabetes and 0.55 (95%CI: 
0.31-0.97) for low TG-HDL diabetes.8 Another study report-
ed sex differences between associations of WBC count and 
risk of CKD;12 no significant associations were seen in men 
while significant positive association were seen in women. 
This is also compatible with our present results, which 
showed sex differences in the association between WBC 
count and risk of CKD. The study reported here found fur-
ther evidence that the positive associations between WBC 
count and diabetes were confined to high TG-HDL diabe-
tes.
　Obesity is associated with an increase in WBC count, and 
bariatric surgery has been shown to lower the WBC count.16,17 
Obesity causes infiltration of the visceral adipose tissue, 
which leads to macrophage accumulation18 and is a major 
determinant of insulin resistance.19 Insulin resistance has 
been found to be enhanced by the link between insulin resis-
tance measures and WBC count, both in a general popula-
tion20 and in non-diabetic subjects.21 Excessive adiposity in-
creases the risk for development of a variety of pathological 
conditions including type 2 diabetes22 and cardiovascular 
disease.23 Furthermore, Ortega et al. reported that WBC 
count was associated with carotid and femoral atherosclero-
sis.11 Therefore, because diabetes combined with a high, but 
not with a low TG-HDL ratio, is mainly caused by insulin 
resistance, which constitutes a risk for atherosclerosis,6 
WBC count is positively associated with high TG-HDL but 
not with low TG-HDL diabetes. The sex differences for the 
relationship between WBC count and diabetes observed in 
our present study might be caused by the sex differential as-
sociation between intermediate TG-HDL diabetes and WBC 
count. For intermediate TG-HDL diabetes, even multivari-
able-OR showed no significant associations for either men 
or women, but women tended to show a positive association. 
Our present additional analysis showed higher prevalence of 
overweight (BMI >25 kg/m2) for women than for men with 
intermediate TG-HDL diabetes; the age-adjusted prevalence 
of overweight was 44.4% for women and 33.9% for men 
(p=0.001). Because a high BMI is strongly associated with 
insulin resistance,25 women with intermediate TG-HDL dia-
betes may show stronger insulin resistance. Our previous 
study, which reported that associations between diabetes and 
BMI for Japanese subjects were strongly influenced by the 
status of TG-HDL, might partly explain those associations.7 
Further studies to assess insulin resistance are necessary.
　Some potential limitations of this study warrant consider-
ation. First, we had no access to data for menopausal status, 
which can strongly influence insulin resistance in women.24 
However, when we performed our analyses only for partici-
pants aged ≥60 years, essentially the same associations were 
observed for women. Nevertheless, further investigations 
including menopausal data are needed. Second, as no data 
regarding exercise were available, we could not make ad-
justments for the effect of exercise. Finally, because this 
study was cross-sectional, we could not establish any causal 
relationships.
　In conclusion, independent of classical cardiovascular 
risk factors, significant positive associations with WBC 
count were observed for both men and women with high 
TG-HDL diabetes but not with low TG-HDL diabetes. These 
Discussion
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